What if ASML Becomes the Next Trillion-Dollar Stock?

Nvidia now anticipates at least $1 trillion in AI chip orders through 2027, supporting strong demand for ASML's EUV lithography systems. ASML (market cap ~ $540B) could reach $1T with mid-teens EPS growth, but currently trades at a premium P/E of 49.3 (forward 39.8) and reported revenue from only two High-NA EUV systems in Q4 2025 versus 94 new lithography units; installed-base service sales comprised ~25% of 2025 revenue. The article is bullish on a long runway driven by massive AI capex (Broadcom forecasted $100B FY27 AI revenue; Big Tech capex ~ $600B in 2026) while flagging valuation vulnerability to a cyclical slowdown.

Analysis

The market is pricing ASML as a growth option on sustained hyper-scale AI capex; that makes its share price a function of multi-year order conversion and yield progress on next-gen High-NA tools rather than quarterly beats. That creates a concentrated exposure to two operational variables: (1) the cadence at which High-NA machines move from prototype to volume and (2) foundry allocation decisions that prioritize which customers get earliest tool slots — both can move realized revenue by multiple percentage points year-to-year.

Second-order winners include consumable and service providers up the stack (photoresist, pellicles, metrology software) and logistics partners that shorten lead times; losers are any DUV-first vendors whose TAM shrinks if customers accelerate migration to EUV/High-NA. Geopolitics and export control noise can create lumpy drawdowns in addressable market access — a ~3-9 month order pause from a single large customer could compress consensus EPS by double digits in the following year if backlog recognition shifts.

Key near-term catalysts are quarterly order disclosures and customer capex cadence from the hyperscalers; medium-term catalysts are demonstrable High-NA yield improvement and broader wafer-start growth at leading foundries over 12–36 months. Tail risks: slower hyperscaler spending, a shift to chiplet/heterogeneous compute that reduces node shrink urgency, or regulatory restrictions limiting access to China — any of which would reprice a growth premium-heavy stock quickly.

Key Decisions for Investors

• ASML directional, limited-risk: Buy ASML Jan-2028 LEAP call spread (buy 1x ATM, sell 1x+30–40% OTM). Timeframe 12–30 months to let High-NA volume and backlog convert. R/R: limited premium (max loss = premium) vs ~2–4x upside if multi-year EPS growth > mid-teens and valuation holds.
• Hedge/relative-value pair: Long ASML / Short LRCX (equal notional). Entry on any post-earnings weakness or order-normalization print (0–3 months). Rationale: hedge cyclical wafer fab order normalisation while keeping asymmetric upside to ASML’s structural EUV oligopoly; target 6–18 month horizon, expect pair to outperform if EUV demand stays sticky and general WFE orders soften. Stop-loss: 8–12% of NAV on pair basis.
• Tail-risk insurance: Purchase 6–9 month ASML puts (10–20% OTM) after next quarterly release if headline guidance remains elevated. Cost: disposable insurance to protect against a 20–40% downside event driven by export controls or hyperscaler capex pause; treat as portfolio tail hedge rather than alpha trade.
• Opportunistic supplier trade: Overweight AMAT/KLAC on any ASML-driven pull-through weakness (3–12 months). These names capture recurring consumables and metrology revenue even if new-machine deliveries slip; expect 12–18% relative upside vs WFE cyclicals if demand re-accelerates. Exit if lead indicators (fab starts, wafer starts) diverge negatively for two consecutive quarters.